Pietrifica Scrieți Prestigiu trougakos ioannis ministru Ca de obicei Amuzant
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Aging | Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model - Full Text
Trougakos Ioannis P - Bioblast
Ioannis Trougakos
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Integrating the DNA damage and protein stress responses during cancer development and treatment - Gorgoulis - 2018 - The Journal of Pathology - Wiley Online Library
University of Athens | Tascmar
Health Reference Center Academic - Document - Comparative meta-analysis of transcriptomics data during cellular senescence and in vivo tissue ageing
Loop | Ioannis Trougakos
Molecular Mechanisms and Models of Aging, Volume 1119 (Annals of the New York Academy of Sciences): 9781573316866: Gonos, Efstathios S., Trougakos, Ioannis P., Chondrogianni, Niki: Books - Amazon.com
Trougakos - Names Encyclopedia
Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays | medRxiv
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
PUBLICATIONS – Plant UP
Identification of new biomarkers and therapeutic targets for MDR tumours - Stratagem
Universal Design: A Step toward Successful Aging – topic of research paper in Psychology. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Scientific Reports Autophagy. - ppt download
Cells | Special Issue : Molecular-Cellular Basis of Ageing and Cancer
Clusterin in Alzheimer's Disease: An Amyloidogenic Inhibitor of Amyloid Formation | Research Square
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients | BMC Medicine | Full Text
30+ "Trougakos" profiles | LinkedIn
Ralph A. Nixon
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts | Scientific Reports